Home/Filings/4/0001610618-21-000020
4//SEC Filing

Sandison Taylor 4

Accession 0001610618-21-000020

CIK 0001610618other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 9:02 PM ET

Size

6.2 KB

Accession

0001610618-21-000020

Insider Transaction Report

Form 4
Period: 2021-03-17
Sandison Taylor
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-03-17+145,000145,000 total
    Exercise: $2.55Exp: 2031-03-16Common Stock (145,000 underlying)
Holdings
  • Common Stock

    81,331
Footnotes (2)
  • [F1]Includes 8,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2020 and November 20, 2020.
  • [F2]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 17, 2021.

Issuer

Cidara Therapeutics, Inc.

CIK 0001610618

Entity typeother

Related Parties

1
  • filerCIK 0001702287

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 9:02 PM ET
Size
6.2 KB